Výpis publikací

ŠTORK, Martin; Sabina ŠEVČÍKOVÁ; Jiri MINARIK; Petra KRHOVSKA; Jakub RADOCHA; Lenka POSPISILOVA; Lucie KUBÍNOVÁ; Jiří JARKOVSKÝ; Ivan SPICKA; Jan STRAUB; Petr PAVLICEK; Alexandra JUNGOVA; Tomas JELINEK; Viera SANDECKÁ; Vladimir MAISNAR; Roman HAJEK a Luděk POUR. Identification of patients at high risk of secondary extramedullary multiple myeloma development. British journal of haematology. England: Wiley-Blackwell, 2022, roč. 196, č. 4, s. 954-962. ISSN 0007-1048. Dostupné z: https://doi.org/10.1111/bjh.17925.

MEDILEK, Karel; Lenka ZALOUDKOVA; Alexander BORG; Lucie KUBÍNOVÁ a Josef STASEK. Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors-single center study. Echocardiography - A Journal of Cardiovascular Ultrasound and Allied Techniques. HOBOKEN: WILEY, 2022, roč. 39, č. 9, s. 1171-1179. ISSN 0742-2822. Dostupné z: https://doi.org/10.1111/echo.15411.

SANDECKÁ, Viera; Luděk POUR; Ivan SPICKA; Jiri MINARIK; Jakub RADOCHA; Tomas JELINEK; Adriana HEINDORFER; Petr PAVLICEK; Michal SYKORA; Alexandra JUNGOVA; Petr KESSLER; Marek WROBEL; David STAROSTKA; Jana ULLRYCHOVA; Lukas STEJSKAL; Martin ŠTORK; Jan STRAUB; Tomas PIKA; Lucie KUBÍNOVÁ; Sabina ŠEVČÍKOVÁ; Vladimir MAISNAR a Roman HAJEK. Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2021, roč. 107, č. 4, s. 466-474. ISSN 0902-4441. Dostupné z: https://doi.org/10.1111/ejh.13683.

CHYRA, Zuzana; Tereza SEVIKOVA; Petr VOJTA; Janka PUTEROVÁ; Lucie KUBÍNOVÁ; Kateřina GROWKOVÁ; Jana FILIPOVA; Martina ZATOPKOVA; Sebastian GROSICKI; Agnieszka BARCHNICKA; Wieslaw WIKTOR-JEDRZEJCZAK; Anna WASZCZUK-GAJDA; Alexandra JUNGOVA; Aneta MIKULASOVA; Marian HAJDÚCH; Martin MOKREJŠ; Luděk POUR; Martin ŠTORK; Lubica HARVANOVA; Martin MISTRIK; Gabor MIKALA; Pawel ROBAK; Anna CZYZ; Jakub DEBSKI; Lidia USNARSKA-ZUBKIEWICZ; Artur JURCZYSZYN; Lukas STEJSKAL; Gareth MORGAN; Fedor KRYUKOV; Eva BUDINSKÁ; Michal SIMICEK; Tomas JELINEK; Matous HRDINKA a Roman HAJEK. Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis. haematologica. Pavia: Ferrata-Storti Foundation, 2021, roč. 106, č. 2, s. 601-604. ISSN 0390-6078. Dostupné z: https://doi.org/10.3324/haematol.2019.239756.

BÚTOVÁ, Romana; Petra VYCHYTILOVÁ; Jana GREGOROVÁ; Lenka RADOVÁ; Martina ALMASI; Renata BEZDEKOVA; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Zdenka KNECHTOVA; Martin ŠTORK; Luděk POUR a Sabina ŠEVČÍKOVÁ. LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients. Biomedicines. Basel: MDPI, 2021, roč. 9, č. 11, s. 1-11. ISSN 2227-9059. Dostupné z: https://doi.org/10.3390/biomedicines9111637.

BEZDĚKOVÁ, Renata; Tomas JELINEK; Romana KRÁLOVÁ; Martin ŠTORK; Petra POLACKOVA; Pavla VŠIANSKÁ; Lucie KUBÍNOVÁ; Jiří JARKOVSKÝ; Martina ALMÁŠI; Ivanna BOICHUK; Zdenka KNECHTOVA; Miroslav PENKA; Luděk POUR; Sabina ŠEVČÍKOVÁ; Roman HAJEK a Lucie ŘÍHOVÁ. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia. British journal of haematology. England: Wiley-Blackwell, 2021, roč. 195, č. 1, s. 95-107. ISSN 0007-1048. Dostupné z: https://doi.org/10.1111/bjh.17713.

MINARIK, J.; T. PIKA; J. RADOCHA; A. JUNGOVA; J. STRAUB; T. JELINEK; Luděk POUR; P. PAVLICEK; M. MISTRIK; Lucie BROŽOVÁ; P. KRHOVSKA; K. MACHALKOVA; P. JINDRA; I. SPICKA; H. PLONKOVA; Martin ŠTORK; J. BACOVSKY; L. CAPKOVA; M. SYKORA; P. KESSLER; L. STEJSKAL; A. HEINDORFER; J. ULLRYCHOVA; T. SKACEL; V. MAISNAR a R. HAJEK. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice. BMC Cancer. LONDON: BMC, 2021, roč. 21, č. 1, s. 1-13. ISSN 1471-2407. Dostupné z: https://doi.org/10.1186/s12885-020-07732-1.

RADOCHA, Jakub; Tomas JELINEK; Luděk POUR; Ivan SPICKA; Jiri MINARIK; Tereza POPKOVA; Alexandra JUNGOVA; Petr PAVLICEK; Lucie BROŽOVÁ; Martin ŠTORK; Frantisek SEDLAK; Petra KRHOVSKA; Vladimir MAISNAR; Adriana HEINDORFER; Michal SYKORA; Marek WROBEL; Peter MIKULA; Petr KESSLER; Jana ULLRYCHOVA a Roman HAJEK. Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation. International Journal of Laboratory Hematology. MALDEN: WILEY-BLACKWELL, 2021, roč. 43, č. 5, s. "E244"-"E247", 4 s. ISSN 1751-5521. Dostupné z: https://doi.org/10.1111/ijlh.13460.

ŠTORK, Martin; Sabina ŠEVČÍKOVÁ; Lucie BROŽOVÁ; I. SPICKA; V. MAISNAR; J. MINARIK; A. JUNGOVA; E. GREGORA; Roberta VELICHOVÁ; R. HAJEK; T. JELINEK a Luděk POUR. Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data. Neoplasma. Bratislava: Slovenská akademie vied, 2020, roč. 67, č. 1, s. 178-184. ISSN 0028-2685. Dostupné z: https://doi.org/10.4149/neo_2019_190430N383.

SANDECKÁ, Viera; Zdeněk ADAM; Marta KREJČÍ; Martin ŠTORK; Zdeněk ŘEHÁK; Renata KOUKALOVÁ; Sabina ŠEVČÍKOVÁ; Lucie BROŽOVÁ; Zdeněk KRÁL; Jiří MAYER a Luděk POUR. Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience. Neoplasma. Bratislava: Slovenská akademie vied, 2020, roč. 67, č. 4, s. 939-945. ISSN 0028-2685. Dostupné z: https://doi.org/10.4149/neo_2020_191104N1137.

VRÁBEL, Dávid; Lenka SEDLARIKOVA; Lenka BESSE; Lucie ŘÍHOVÁ; Renata BEZDEKOVA; Martina ALMÁŠI; Veronika KUBACZKOVÁ; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Hana PLONKOVA; Tomas JELINEK; Viera SANDECKA; Martin STORK; Luděk POUR; Sabina ŠEVČÍKOVÁ a Roman HAJEK. Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2020, roč. 104, č. 3, s. 190-197. ISSN 0902-4441. Dostupné z: https://doi.org/10.1111/ejh.13358.

HÁJEK, Roman; Viera SANDECKÁ; Ivan ŠPIČKA; Marc RAAB; Hartmut GOLDSCHMIDT; Susanne BECK; Jiří MINAŘÍK; Petr PAVLÍČEK; Jakub RADOCHA; Adriana HEINDORFER; Tomáš JELÍNEK; Lukáš STEJSKAL; Lucie BROŽOVÁ; Sabina ŠEVČÍKOVÁ; Jan STRAUB; Tomáš PIKA; Luděk POUR; Vladimír MAISNAR; Anja SECKINGER a Dirk HOSE. Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model. British journal of haematology. Hoboken: Wiley-Blackwell, 2020, roč. 190, č. 2, s. 189-197. ISSN 0007-1048. Dostupné z: https://doi.org/10.1111/bjh.16572.

GARCES, J. J.; M. SIMICEK; M. VICARI; Lucie BROŽOVÁ; L. BURGOS; R. BEZDEKOVA; D. ALIGNANI; M. J. CALASANZ; K. GROWKOVA; I. GOICOECHEA; X. AGIRRE; L. POUR; F. PROSPER; R. RIOS; J. MARTINEZ-LOPEZ; P. MILLACOY; L. PALOMERA; R. DEL ORBE; A. PEREZ-MONTANA; S. GARATE; L. BLANCO; M. LASA; P. MAISO; J. FLORES-MONTERO; L. SANOJA-FLORES; Zuzana CHYRA; A. VDOVIN; T. SEVCIKOVA; T. JELINEK; C. BOTTA; H. EL OMRI; J. KEATS; A. ORFAO; R. HAJEK; J. F. SAN-MIGUEL a B. PAIVA. Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination. Leukemia. London: Nature Publishing Group, 2020, roč. 34, č. 2, s. 589-603. ISSN 0887-6924. Dostupné z: https://doi.org/10.1038/s41375-019-0588-4.

MAISNAR, V.; Z. STEFANIKOVA; I. SPICKA; Luděk POUR; J. MINARIK; M. FLOCHOVA; J. RADOCHA; E. GREGORA; N. STECOVA; T. JELINEK; A. JUNGOVA; E. KRALIKOVA; Lucie BROŽOVÁ a R. HAJEK. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. Neoplasma. Bratislava: Slovenská akademie vied, 2019, roč. 66, č. 3, s. 499-505. ISSN 0028-2685. Dostupné z: https://doi.org/10.4149/neo_2018_180824N644.

BOUWMEESTER, Walter; Andrew BRIGGS; Ben VAN HOUT; Roman HAJEK; Sebastian GONZALEZ-MCQUIRE; Marco CAMPIONI; Lucy DECOSTA a Lucie BROŽOVÁ. Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting. ONCOLOGY AND THERAPY. NEW YORK: SPRINGER, 2019, roč. 7, č. 2, s. 141-157. ISSN 2366-1070. Dostupné z: https://doi.org/10.1007/s40487-019-00100-5.

MINARIK, J.; T. PIKA; J. RADOCHA; A. JUNGOVA; J. STRAUB; T. JELINEK; Luděk POUR; P. PAVLICEK; M. MISTRIK; Lucie BROŽOVÁ; P. KRHOVSKA; K. MACHALKOVA; P. JINDRA; I. SPICKA; H. PLONKOVA; Martin ŠTORK; J. BACOVSKY; L. CAPKOVA; M. SYKORA; P. KESSLER; L. STEJSKAL; A. HEINDORFER; J. ULLRYCHOVA; V. MAISNAR a R. HAJEK. Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma. In 17th International Myeloma Workshop. 2019. ISSN 2152-2650. Dostupné z: https://doi.org/10.1016/j.clml.2019.09.448.

RADOCHA, J.; Roman HÁJEK; Lucie BROŽOVÁ; Luděk POUR; I. ŠPIČKA; J. MINAŘÍK; E. GREGORA; A. JUNGOVÁ; T. JELÍNEK; A. HEINDORFER; M. SÝKORA a V. MAISNAR. Simplified novel prognostic score for real-life older adults with multiple myelomaregistry-based analysis. Annals of hematology. New York: Springer Verlag, 2019, roč. 98, č. 4, s. 951-962. ISSN 0939-5555. Dostupné z: https://doi.org/10.1007/s00277-018-3568-2.

MINARIK, Jiri; Ludek POUR; Vladimir MAISNAR; Ivan SPICKA; Alexandra JUNGOVA; Tomas JELINEK; Lucie BROŽOVÁ; Petra KRHOVSKA; Vlastimil SCUDLA a Roman HAJEK. Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2019, roč. 163, č. 3, s. 279-283. ISSN 1213-8118. Dostupné z: https://doi.org/10.5507/bp.2018.064.

JELINEK, T.; V. MAISNAR; Luděk POUR; I. SPICKA; J. MINARIK; E. GREGORA; P. KESSLER; M. SYKORA; H. FRANKOVA; D. ADAMOVA; M. WROBEL; P. MIKULA; Jiří JARKOVSKÝ; J. DIELS; X. GATOPOULOU; S. VESELA; H. BESSON; Lucie BROŽOVÁ; T. ITO a R. HAJEK. Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. Current medical research and opinion. Oxon: Taylor & Francis, 2018, roč. 34, č. 5, s. 775-783. ISSN 0300-7995. Dostupné z: https://doi.org/10.1080/03007995.2017.1410121.

SEDLAŘÍKOVÁ, Lenka; Božena BOLLOVÁ; Lenka RADOVÁ; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Martina ALMÁŠI; Miroslav PENKA; Petr KUGLÍK; Viera SANDECKÁ; Martin ŠTORK; Luděk POUR a Sabina ŠEVČÍKOVÁ. Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies. Hematological Oncology. MALDEN, USA: WILEY-BLACKWELL, 2018, roč. 36, č. 5, s. 786-791. ISSN 0278-0232. Dostupné z: https://doi.org/10.1002/hon.2554.

ŠTORK, Martin; Sabina ŠEVČÍKOVÁ; Zdeněk ADAM; Marta KREJČÍ; Viera SANDECKÁ; Zdeněk KRÁL; Lucie BROŽOVÁ; Roberta VELICHOVÁ a Luděk POUR. Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients. Neoplasma. Bratislava: Slovenská akademie vied, 2018, roč. 65, č. 4, s. 585-591. ISSN 0028-2685. Dostupné z: https://doi.org/10.4149/neo_2018_170519N363.

ALMÁŠI, Martina; L. BESSE; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Renata BEZDĚKOVÁ; Luděk POUR; J. MINARIK; P. KESSLER; P. PAVLICEK; L. ROZIAKOVA; Miroslav PENKA; Roman HÁJEK; Anna VAŠKŮ a Sabina ŠEVČÍKOVÁ. Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients. Klinická onkologie. Praha: Ambit Media, 2018, roč. 31, č. 3, s. 213-229. ISSN 0862-495X.

GARCES, JJ; M SIMICEK; M VICARI; Lucie BROŽOVÁ; L BURGOS; Renata BEZDĚKOVÁ; D ALIGNANI; MJ CALASANZ; Kateřina GROWKOVÁ; Luděk POUR; R RIOS; J MARTINEZ-LOPEZ; P MILLACOY; L PALOMERA; Orbe R DEL; S GARATE; L BLANCO; P MAISO; Z CHYRA; A VDOVIN; T JELINEK; C BOTTA; Omri H EL; X AGIRRE; F PROSPER; Roman HÁJEK; JF SAN-MIGUEL a B PAIVA. Transcriptomic Profiling of Circulating Tumor Cells (CTCs) in Multiple Myeloma (MM): A New Model to Understand Disease Dissemination. 2018. Dostupné z: https://doi.org/10.1182/blood-2018-99-113331.

RADOCHA, Jakub; Vladimír MAISNAR; Luděk POUR; Ivan ŠPIČKA; Jiří MINAŘÍK; Lenka SZELIGOVÁ; Petr PAVLÍČEK; Alexandra JUNGOVÁ; Marta KREJČÍ; Tomáš PIKA; Jan STRAUB; Lucie BROŽOVÁ; Lukáš STEJSKAL; Adriana HEINDORFER; Pavel JINDRA; Petr KESSLER; Peter MIKULA; Michal SYKORA; Marek WRÓBEL; Jiří JARKOVSKÝ a Roman HAJEK. Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies. Cancer Medicine. Houston: John Wiley & Sons Ltd., 2018, roč. 7, č. 8, s. 4132-4145. ISSN 2045-7634. Dostupné z: https://doi.org/10.1002/cam4.1620.

SANDECKÁ, Viera; Roman HÁJEK; Luděk POUR; I. SPICKA; V. SCUDLA; E. GREGORA; J. RADOCHA; L. WALTEROVA; P. KESSLER; L. ZAHRADOVA; D. ADAMOVA; K. VALENTOVA; I. VONKE; J. OBERNAUEROVA; D. STAROSTKA; M. WROBEL; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Aneta MIKULÁŠOVÁ; L. RIHOVA; Sabina ŠEVČÍKOVÁ; J. STRAUB; J. MINARIK; Zdeněk ADAM; Marta KREJČÍ; Zdeněk KRÁL a V. MAISNAR. A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2017, roč. 99, č. 1, s. 80-90. ISSN 0902-4441. Dostupné z: https://doi.org/10.1111/ejh.12894.

BROŽOVÁ, Lucie; Jiří JARKOVSKÝ; Luděk POUR; J. MINARIK; A. JUNGOVA; E. GREGORA; I. SPICKA; V. MAISNAR a R. HAJEK. Asymptomatic and Treatment-requering Multiple Myeloma – Data from the Czech Registry of Monoclonal Gammopathies. Klinická onkologie. Praha: Ambit Media, 2017, roč. 30, Suppl. 2, s. "2S51"-"2S59", 9 s. ISSN 0862-495X.

KUFOVA, Z.; T. SEVCIKOVA; K. GROWKOVA; P. VOJTA; J. FILIPOVA; Zdeněk ADAM; Luděk POUR; Miroslav PENKA; R. RYSAVA; Pavel NĚMEC; Lucie BROŽOVÁ; Petra VYCHYTILOVÁ; A. JURCZYSZYN; S. GROSICKI; A. BARCHNICKA; M. HAJDUCH; M. SIMICEK a R. HAJEK. Biomarkers in immunoglobulin light chain amyloidosis. Klinická onkologie. Praha: Ambit Media, 2017, roč. 30, Suppl. 2, s. "2S60"-"2S67", 8 s. ISSN 0862-495X. Dostupné z: https://doi.org/10.14735/amko20172S60.

BROŽOVÁ, Lucie; Daniel SCHWARZ; Ivo ŠNÁBL; Jiří KALINA; B. PAVLICKOVA; Martin KOMENDA; Jiří JARKOVSKÝ; P. NEMEC; D. HORINEK; Z. STEFANIKOVA; Luděk POUR; R. HAJEK a V. MAISNAR. Czech Registry of Monoclonal Gammopathies – Technical Solution, Data Collection and Visualisation. Klinická onkologie. Praha: Ambit Media, 2017, roč. 30, Suppl. 2, s. "2S43"-"2S50", 8 s. ISSN 0862-495X. Dostupné z: https://doi.org/10.14735/amko20172S43.

SEDLAŘÍKOVÁ, Lenka; Barbora GROMESOVÁ; Veronika KUBACZKOVÁ; Lenka RADOVÁ; Jana FILIPOVA; Jiří JARKOVSKÝ; Lucie BROŽOVÁ; Roberta VELICHOVÁ; Martina ALMÁŠI; Miroslav PENKA; Renata BEZDĚKOVÁ; Martin ŠTORK; Zdeněk ADAM; Luděk POUR; Marta KREJČÍ; Petr KUGLÍK; Roman HÁJEK a Sabina ŠEVČÍKOVÁ. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma. European Journal of Haematology. Hoboken: Wiley-Blackwell, 2017, roč. 99, č. 3, s. 223-233. ISSN 0902-4441. Dostupné z: https://doi.org/10.1111/ejh.12908.

MALÚŠKOVÁ, Denisa; Ivana SVOBODOVÁ; Michaela ZAPLETALOVÁ; Lucie BROŽOVÁ; Jan MUŽÍK; Jiří JARKOVSKÝ; R. HÁJEK; V. MAISNAR a Ladislav DUŠEK. Epidemiology of Multiple Myeloma in the Czech Republic. Klinická onkologie. Praha: Ambit Media, 2017, roč. 30, Suppl. 2, s. "2S35"-"2S42", 8 s. ISSN 0862-495X. Dostupné z: https://doi.org/10.14735/amko20172S35.

CASTILLO, J.J.; A. JURCZYSZYN; Lucie BROŽOVÁ; E. CRUSOE; J. CZEPIEL; J. DAVILA; A. DISPENZIERI; M. EVEILLARD; M.A. FIALA; I.M. GHOBRIAL; A. GOZZETTI; J.N. GUSTINE; R. HAJEK; V. HUNGRIA; Jiří JARKOVSKÝ; D. JAYABALAN; J.P. LAUBACH; B. LEWICKA; V. MAISNAR; E.E. MANASANCH; P. MOREAU; E.A. MORGAN; H. NAHI; R. NIESVIZKY; C. PABA-PRADA; T. PIKA; Luděk POUR; J.L. REAGAN; P.G. RICHARDSON; J. SHAH; I. SPICKA; R. VIJ; A. WASZCZUK-GAJDA a M.A. GERTZ. IgM myeloma: A multicenter retrospective study of 134 patients. American Journal of Hematology. Hoboken: Wiley, 2017, roč. 92, č. 8, s. 746-751. ISSN 0361-8609. Dostupné z: https://doi.org/10.1002/ajh.24753.

HAJEK, Roman; Tomas JELINEK; Vladimir MAISNAR; Luděk POUR; Ivan SPICKA; Jiri MINARIK; Evzen GREGORA; Petr KESSLER; Michal SYKORA; Hana FRANKOVA; Dagmar ADAMOVA; Marek WROBEL; Peter MIKULA; Jiří JARKOVSKÝ; Xenia GATOPOULOU; Sarka VESELA; Joris DIELS; Herve BESSON; Lucie BROŽOVÁ a Tetsuro ITO. Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients. In 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). 2016. ISSN 0006-4971. Dostupné z: https://doi.org/10.1182/blood.V128.22.3332.3332.

KRYUKOV, Fedor; Elena Vladimirovna KRYUKOVA; Lucie BROŽOVÁ; Zuzana KUFOVA; Jana FILIPOVA; Katerina GROWKOVA; Tereza SEVCIKOVA; Jiří JARKOVSKÝ a Roman HÁJEK. Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview. Gene. Amsterdam: Elsevier Science, 2016, roč. 591, č. 2, s. 490-498. ISSN 0378-1119. Dostupné z: https://doi.org/10.1016/j.gene.2016.06.017.

ŠTOURAČ, Petr; Jan BLAHA; Radka KLOZOVA; Pavlina NOSKOVA; Dagmar SEIDLOVÁ; Lucie BROŽOVÁ a Jiří JARKOVSKÝ. Anesthesia for Cesarean Delivery in the Czech Republic: A 2011 National Survey. Anesthesia and Analgesia. Cleveland: Lippincott Williams & Wilkins, 2015, roč. 120, č. 6, s. 1303-1308. ISSN 0003-2999. Dostupné z: https://doi.org/10.1213/ANE.0000000000000572.

KUGLÍK, Petr; Kateřina KAŠÍKOVÁ; Jan SMETANA; Vladimíra VALLOVÁ; Anna LAŠTŮVKOVÁ; Lucie MOUKOVÁ; Michaela CVANOVÁ a Lucie BROŽOVÁ. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas. Neoplasma. Slovenská akademie vied, 2015, roč. 62, č. 1, s. 130-139. ISSN 0028-2685. Dostupné z: https://doi.org/10.4149/neo_2015_017.

SANDECKÁ, V.; R. HÁJEK; Zdeněk ADAM; I. ŠPIČKA; V. ŠČUDLA; E. GREGORA; J. RADOCHA; L. WALTEROVÁ; P. KESSLER; D. ADAMOVÁ; K. VALENTOVÁ; I. VONKE; L. ULMANOVÁ; D. STAROSTKA; M. WRÓBEL; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Aneta MIKULÁŠOVÁ; L. ŘÍHOVÁ; Martina ALMÁŠI; Sabina ŠEVČÍKOVÁ; Marta KREJČÍ; J. STRAUB; J. MINAŘÍK; P. PAVLÍČEK; Luděk POUR; Pavla VŠIANSKÁ; Samuel Adeyinka OKUBOTE; Miroslav PENKA a V. MAISNAR. Monoklonalní gamapatie nejasného významu s nízkým a vysokým stupněm rizika: výstupy z analýz RMG registru České myelomové skupiny pro praxi. Klinická biochemie a metabolismus. Pardubice: Stapro, 2015, roč. 23, č. 2, s. 53-59. ISSN 1210-7921.

MINARIK, Jiri; Petr PAVLICEK; Luděk POUR; Tomas PIKA; Vladimir MAISNAR; Ivan SPICKA; Jiří JARKOVSKÝ; Marta KREJČÍ; Jaroslav BACOVSKY; Jakub RADOCHA; Jan STRAUB; Petr KESSLER; Marek WROBEL; Lenka WALTEROVA; Michal SYKORA; Jarmila OBERNAUEROVA; Lucie BROŽOVÁ; Evzen GREGORA; Dagmar ADAMOVA; Jaromir GUMULEC; Zdeněk ADAM; Vlastimil SCUDLA a Roman HAJEK. Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy. PLOS ONE. San Francisco: Public Library Science, 2015, roč. 10, č. 4, s. "e0123866-1"-"e0123866-10", 10 s. ISSN 1932-6203. Dostupné z: https://doi.org/10.1371/journal.pone.0123866.

KUGLÍK, Petr; Jan SMETANA; Vladimíra VALLOVÁ; Lucie MOUKOVÁ; Kateřina KAŠÍKOVÁ; Michaela CVANOVÁ a Lucie BROŽOVÁ. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH. International Journal of Clinical and Experimental Pathology. USA: e-Century Publishing Corporation, Madiso, 2014, roč. 7, č. 8, s. 5071-5082. ISSN 1936-2625.

KURICOVÁ, Katarína; Veronika DVOŘÁKOVÁ; Lukáš PÁCAL; Vendula BARTÁKOVÁ; Lucie BROŽOVÁ; Jiří JARKOVSKÝ a Kateřina KAŇKOVÁ. NOS3 894G > T Polymorphism is Associated With Progression of Kidney Disease and Cardiovascular Morbidity in Type 2 Diabetic Patients: NOS3 as a Modifier Gene for Diabetic Nephropathy? Kidney and Blood Pressure Research. Karger, 2014, roč. 38, č. 1, s. 92-98. ISSN 1420-4096. Dostupné z: https://doi.org/10.1159/000355757.

ALMAŠI, Martina; Barbora SÁBLÍKOVÁ; Lenka KUBICZKOVÁ; Sabina ŠEVČÍKOVÁ; Fedor KRYUKOV; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Michal JURAJDA; Zdeněk ADAM; Z. ŠTEFANIKOVÁ; Miroslav PENKA; Anna VAŠKŮ a Roman HÁJEK. Association of SNPs in P-glycoprotein 1 with Longer Time to Event in Bortezomib-treated Multiple Myeloma Patients. In 14th International Myeloma Workshop. 2013. ISSN 2152-2650.

KRYUKOV, Fedor; Elena Vladimirovna DEMENTYEVA; Lenka KUBICZKOVÁ; Jiří JARKOVSKÝ; Lucie BROŽOVÁ; Jakub PETRÍK; Pavel NĚMEC; Sabina ŠEVČÍKOVÁ; Jiri MINARIK; Zdena STEFANIKOVA; Petr KUGLÍK a Roman HÁJEK. Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia. Genomics. United States: Elsevier Science Inc, 2013, roč. 102, č. 4, s. 243-249. ISSN 0888-7543. Dostupné z: https://doi.org/10.1016/j.ygeno.2013.06.007.

KRYUKOV, Fedor; Elena Vladimirovna DEMENTYEVA; Lenka KUBICZKOVÁ; Sabina ŠEVČÍKOVÁ; Jiří JARKOVSKÝ; Lucie BROŽOVÁ; Pavel NĚMEC; Lenka ZAHRADOVÁ; Luděk POUR a Roman HÁJEK. Cell Cycle Genes Coexpression in Multiple Myeloma and Plasma Cell Leukemia. In 14th International Myeloma Workshop. 2013. ISSN 2152-2650.

ALMAŠI, Martina; Barbora SÁBLÍKOVÁ; Lenka KUBICZKOVÁ; Sabina ŠEVČÍKOVÁ; Fedor KRYUKOV; Lucie BROŽOVÁ; Jiří JARKOVSKÝ; Michal JURAJDA; Zdeněk ADAM; Miroslav PENKA; Anna VAŠKŮ a Roman HÁJEK. Polymorfismy v genu P-glycoprotein 1 souvisí s intervaly přežití u nemocných s mnohočetným myelomem léčených bortezomibem. In XXVII. Olomoucké hematologické dny s mezinárodní účastí. 2013.